SCHEMBL25543136

SCHEMBL25543136

CCOC(=O)c1ccc(N)c(N(C)C)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.54
ALDH1A1 P00352 7/20 0.47
KMT2A Q03164 3/20 0.47
MAPT P10636 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
MEN1 O00255 1/20 0.47
POLB P06746 2/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
CDC7 O00311 2/20 0.44
DBF4 Q9UBU7 2/20 0.44
HSD17B10 Q99714 2/20 0.44
LMNA P02545 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAOA P21397 1/20 0.42
GAA P10253 1/20 0.40
HPGD P15428 2/20 0.39
KDM4E B2RXH2 2/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13209507 0.83 ALDH1A1 (0.41) CYP1A2ALDH1A1KMT2AMAPTNPC1
SCHEMBL19306385 0.81 CYP1A2 (0.61) CYP1A2ALDH1A1KMT2AMAPTNPC1
SCHEMBL25543467 0.78 CYP1A2 (0.57) CYP1A2ALDH1A1KMT2AMAPTNPC1
SCHEMBL16931364 0.77 CYP1A2 (0.56) CYP1A2ALDH1A1KMT2AMAPTNPC1
SCHEMBL25542615 0.76 CYP1A2 (0.54) CYP1A2ALDH1A1KMT2AMAPTNPC1
SCHEMBL13853230 0.73 CYP1A2 (0.59) CYP1A2ALDH1A1KMT2AMAPTNPC1
SCHEMBL27955600 0.72 CYP1A2 (0.57) CYP1A2ALDH1A1KMT2AMAPTNPC1
SCHEMBL1695597 0.71 CYP1A2 (0.49) CYP1A2ALDH1A1KMT2AMAPTNPC1
SCHEMBL29677764 0.71 CYP1A2 (0.77) CYP1A2ALDH1A1KMT2AMAPTNPC1
SCHEMBL465841 0.71 CYP1A2 (0.77) CYP1A2ALDH1A1KMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165846-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165846-A1 HETEROCYCLIC GLP-1 AGONISTS GLP1R, GIPR, GCGR CYP1A2 1313/4885ALDH1A1 1368/4885KMT2A 4117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.